Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer H Martin

Showing results (71-80 of 184) with videos related to

Pageof 19
Sort By:
British Journal of Clinical Pharmacology|October 29, 2015
Adding the 'medicines' back into personalized medicine to improve cancer treatment outcomesJennifer H Martin, Elizabeth Phillips, David Thomas, et al.
Frontiers in Medicine|June 18, 2024
The need for a change in medical research thinking. Eco-systemic research frames are better suited to explore patterned disease behaviorsJoachim P Sturmberg, Jennifer H Martin, Francesco Tramonti, et al.
British Journal of Clinical Pharmacology|September 17, 2015
Repurposing some older drugs that cross the blood-brain barrier and have potential anticancer activity to provide new treatment options for glioblastomaDayle Rundle-Thiele, Richard Head, Leah Cosgrove, et al.
Journal of Pain & Palliative Care Pharmacotherapy|February 9, 2019
Laxative Use in Inpatients on Oxycodone/Naloxone Prolonged Release and Oxycodone Prolonged Release for Cancer and Non-cancer PainJoanne Patel, Catherine J Lucas, Maxwell Margalit, et al.
British Journal of Clinical Pharmacology|February 12, 2024
Economic evaluation of personalized vs. standard dosing of 5-fluorouracil in first-line chemotherapy for metastatic colorectal cancer in AustraliaDaniel Erku, Jennifer H Martin, Michael Michael, et al.
Biochemia Medica|November 26, 2013
Policy change to improve pathology turnaround time and reduce costs--possible to do both?Goce Dimeski, Breeann Silvester, Jacobus Ungerer, et al.
The Medical Journal of Australia|December 16, 2014
Enabling the success of academic health science centres in Australia: where is the leadership?David E Theile, Ian A Scott, Jennifer H Martin, et al.
The Medical Journal of Australia|August 4, 2009
Doctors and the pharmaceutical industry: time for a national policy?Jennifer H Martin, Christopher Beer, Raymond G Morris, et al.
British Journal of Clinical Pharmacology|August 12, 2011
Therapeutic drug monitoring of antimicrobialsJason A Roberts, Ross Norris, David L Paterson, et al.
Cancer Chemotherapy and Pharmacology|June 14, 2016
Monte Carlo simulations of the clinical benefits from therapeutic drug monitoring of sunitinib in patients with gastrointestinal stromal tumoursSebastiaan C Goulooze, Peter Galettis, Alan V Boddy, et al.
Pageof 19

Showing results (71-80 of 184) with videos related to

Sort By:
Pageof 19
British Journal of Clinical Pharmacology|October 29, 2015
Adding the 'medicines' back into personalized medicine to improve cancer treatment outcomesJennifer H Martin, Elizabeth Phillips, David Thomas, et al.
Frontiers in Medicine|June 18, 2024
The need for a change in medical research thinking. Eco-systemic research frames are better suited to explore patterned disease behaviorsJoachim P Sturmberg, Jennifer H Martin, Francesco Tramonti, et al.
British Journal of Clinical Pharmacology|September 17, 2015
Repurposing some older drugs that cross the blood-brain barrier and have potential anticancer activity to provide new treatment options for glioblastomaDayle Rundle-Thiele, Richard Head, Leah Cosgrove, et al.
Journal of Pain & Palliative Care Pharmacotherapy|February 9, 2019
Laxative Use in Inpatients on Oxycodone/Naloxone Prolonged Release and Oxycodone Prolonged Release for Cancer and Non-cancer PainJoanne Patel, Catherine J Lucas, Maxwell Margalit, et al.
British Journal of Clinical Pharmacology|February 12, 2024
Economic evaluation of personalized vs. standard dosing of 5-fluorouracil in first-line chemotherapy for metastatic colorectal cancer in AustraliaDaniel Erku, Jennifer H Martin, Michael Michael, et al.
Biochemia Medica|November 26, 2013
Policy change to improve pathology turnaround time and reduce costs--possible to do both?Goce Dimeski, Breeann Silvester, Jacobus Ungerer, et al.
The Medical Journal of Australia|December 16, 2014
Enabling the success of academic health science centres in Australia: where is the leadership?David E Theile, Ian A Scott, Jennifer H Martin, et al.
The Medical Journal of Australia|August 4, 2009
Doctors and the pharmaceutical industry: time for a national policy?Jennifer H Martin, Christopher Beer, Raymond G Morris, et al.
British Journal of Clinical Pharmacology|August 12, 2011
Therapeutic drug monitoring of antimicrobialsJason A Roberts, Ross Norris, David L Paterson, et al.
Cancer Chemotherapy and Pharmacology|June 14, 2016
Monte Carlo simulations of the clinical benefits from therapeutic drug monitoring of sunitinib in patients with gastrointestinal stromal tumoursSebastiaan C Goulooze, Peter Galettis, Alan V Boddy, et al.
Pageof 19